<DOC>
	<DOC>NCT01454063</DOC>
	<brief_summary>The purpose of this study is to determine the safety and efficacy of OMS302 (the study drug) for maintaining intraoperative mydriasis in individuals undergoing Intraocular Lens Replacement (ILR) surgery.</brief_summary>
	<brief_title>Safety and Efficacy of OMS302 in Subjects Undergoing Intraocular Lens Replacement With Phacoemulsification</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Competent and willing to voluntarily provide informed consent 18 years of age or older In good general health needing to undergo cataract extraction or lens extraction with lens replacement surgery in one eye, under topical anesthesia No allergies to the medications and/or the active ingredients of any of the study medications No medications with the same activities of the active ingredients in OMS302 for defined time intervals prior to and after surgery No other significant eye injuries, eye conditions or general medical conditions likely to interfere with the evaluation of the study medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2014</verification_date>
	<keyword>cataract</keyword>
	<keyword>lens replacement</keyword>
</DOC>